Emergent Biosolutions Inc. | Ownership
Companies that own Emergent Biosolutions Inc.
BlackRock Fund Advisors
5,023,304
10.03%
835,977
0.02%
06/30/2018
The Vanguard Group, Inc.
4,223,331
8.44%
118,194
0.01%
06/30/2018
Renaissance Technologies LLC
2,066,511
4.13%
198,600
0.13%
06/30/2018
Dimensional Fund Advisors LP
2,036,284
4.07%
-169,280
0.03%
06/30/2018
SSgA Funds Management, Inc.
1,969,803
3.94%
239,684
0.01%
06/30/2018
Acadian Asset Management LLC
1,519,346
3.04%
-180,477
0.24%
06/30/2018
Aberdeen Asset Management, Inc.
1,435,329
2.87%
-68,969
1.33%
06/30/2018
Northern Trust Investments, Inc.
1,153,295
2.31%
120,209
0.02%
06/30/2018
Rice, Hall, James & Associates LLC
1,141,021
2.27%
174,614
2.39%
06/30/2018
Snyder Capital Management LP
1,132,822
2.27%
-91,555
3.07%
06/30/2018
| Address |
400 Professional Drive
Gaithersburg Maryland 20879
United States
|
|
Employees
|
- |
| Website |
http://www.emergentbiosolutions.com |
| Updated |
07/08/2019 |
| Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures that address public health and national security threats. It includes Chemical, Biological, Radiological, Nuclear and Explosive or CBRNE threats; as well as emerging infectious diseases. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. |
